LadRx: A Micro-Cap Shell With More Questions Than Answers

LADX enters the final days of April as one of the stranger stories in the OTC universe — a stock trading at penny-level prices, with a reported +855% weekly price surge, yet carrying the hallmarks of a largely dormant shell.

The price data demands an immediate caveat. The last recorded close is $0.105, dated April 20 — ten days stale by today. The implied weekly gain of over 850% and a one-month move of roughly 106% are not live market readings. They reflect a single price observation against an even older baseline. LadRx has a reported market cap of just $52,000, which places it firmly in shell-company territory. There is no current trading data to support any narrative about momentum, and readers should treat the price figures as illustrative of volatility rather than a confirmed trend.

The short position picture is similarly frozen in time. ORTEX's most recent combined estimate dates to November 2025, putting short interest at roughly 1.2% of the free float — a modest level, but one that arrived via a spectacular jump. The weekly change in that November reading was over 12,000%, up from near-zero in late October. The official FINRA fortnightly figure, dated April 15, 2026, records just 180 shares short — negligible for any practical purpose. These two readings are not contradictory; the ORTEX estimate captures a brief late-2025 flurry that has since entirely unwound. Availability is effectively unlimited, with the ORTEX figure showing 9,999% — far more shares available to borrow than there are shares currently borrowed.

The lending market reflects complete disinterest from short sellers. Utilization has been at 0% every single day since at least mid-March 2026, even though the 52-week peak reached 91%. The cost-to-borrow data is itself six months old at 6.4%. None of these readings describe an active, contested stock — they describe a name where the lending market has gone quiet.

Earnings history carries the most genuinely telling data. LadRx has logged back-to-back post-event drops of 78% — both the April 2 and March 25 events recorded a one-day move of -78.4%. The November 2025 print bucked that pattern with a 54% jump. There is no next earnings event on the calendar. Factor scores show a short-score rank of 82 (out of 100) and a utilization rank of 92, but these percentile rankings reflect the historical period when positioning was briefly elevated — not the current picture, where both readings have reset to zero.

All institutional ownership data is over a year old; the one listed holder is an individual with 0.68% of shares. Insider trade data is from 2020 at the earliest, with the most recent cluster being August 2020 sales at $0.67 per share. Nothing in the available record points to active institutional engagement or fresh insider conviction. What to watch next is straightforward: any regulatory filing, reverse merger announcement, or name-change notice would be the clearest signal that this shell is becoming something new — until then, the data here describes a company more notable for its absence of activity than for anything currently happening in the market.